A detailed history of Israel Englander (Millennium Management LLC) transactions in Johnson & Johnson stock. As of the latest transaction made, Millennium Management LLC holds 545,200 shares of JNJ stock, worth $83.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
545,200
Previous 689,200 20.89%
Holding current value
$83.5 Million
Previous $101 Million 12.29%
% of portfolio
0.04%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $145 Million - $167 Million
-995,600 Reduced 92.44%
81,373 $13.2 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $128 Million - $140 Million
-885,145 Reduced 45.11%
1,076,973 $157 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $275 Million - $288 Million
1,770,538 Added 924.18%
1,962,118 $310 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $226 Million - $247 Million
-1,551,617 Reduced 89.01%
191,580 $30 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $138 Million - $149 Million
896,341 Added 105.84%
1,743,197 $289 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $71.3 Million - $85.1 Million
472,024 Added 125.93%
846,856 $131 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $83.5 Million - $93.7 Million
-521,381 Reduced 58.18%
374,832 $66.2 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $113 Million - $126 Million
701,574 Added 360.45%
896,213 $146 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $29.6 Million - $32.8 Million
176,283 Added 960.36%
194,639 $34.6 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $34.5 Million - $39.2 Million
-218,313 Reduced 92.24%
18,356 $3.25 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $16.7 Million - $18.6 Million
107,266 Added 82.89%
236,669 $40.5 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $196 Million - $217 Million
-1,211,177 Reduced 90.35%
129,403 $20.9 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $147 Million - $158 Million
921,641 Added 219.99%
1,340,580 $221 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $189 Million - $211 Million
-1,237,603 Reduced 74.71%
418,939 $68.9 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $211 Million - $242 Million
1,539,427 Added 1314.46%
1,656,542 $261 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $106 Million - $116 Million
-757,039 Reduced 86.6%
117,115 $17.4 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $66 Million - $79.7 Million
512,211 Added 141.52%
874,154 $123 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $83.2 Million - $115 Million
-748,541 Reduced 67.41%
361,943 $47.5 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $54.9 Million - $63.1 Million
430,885 Added 63.4%
1,110,484 $162 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $59.6 Million - $66.7 Million
469,545 Added 223.54%
679,599 $87.9 Million
Q2 2019

Aug 15, 2019

SELL
$131.15 - $144.24 $72.7 Million - $79.9 Million
-554,044 Reduced 72.51%
210,054 $29.3 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $26 Million - $28.6 Million
198,526 Added 35.1%
764,098 $37.1 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $2.69 Million - $3 Million
21,436 Added 3.94%
565,572 $79.1 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $122 Million - $147 Million
-995,099 Reduced 64.65%
544,136 $70.2 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $51 Million - $59.9 Million
-419,072 Reduced 21.4%
1,539,235 $213 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $123 Million - $136 Million
1,032,162 Added 111.45%
1,958,307 $238 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $10.5 Million - $12.4 Million
-83,767 Reduced 8.29%
926,145 $119 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $75.5 Million - $82.6 Million
575,038 Added 132.23%
1,009,912 $141 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $56.3 Million - $58.9 Million
434,874
434,874 $56.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.